Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2004 Feb;75(2):213–220.

Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study

J Kassubek 1, F Juengling 1, T Kioschies 1, K Henkel 1, J Karitzky 1, B Kramer 1, D Ecker 1, J Andrich 1, C Saft 1, P Kraus 1, A Aschoff 1, A Ludolph 1, G Landwehrmeyer 1
PMCID: PMC1738932  PMID: 14742591

Abstract

Objectives: To analyse grey matter changes in early stages of Huntington's disease using magnetic resonance imaging (MRI) and the technique of voxel based morphometry (VBM).

Methods: Forty four patients with a molecularly confirmed clinical diagnosis of Huntington's disease based on the presence of motor signs were included in the study. Patients were clinically rated using the Unified Huntington's Disease Rating Scale; all were in early clinical stages of the disease (that is, Shoulson stages I and II). High resolution volume rendering MRI scans (MP-RAGE) were acquired. MRI data were volumetrically analysed in comparison to an age matched normal database by VBM, using statistical parametric mapping (SPM99).

Results: In Huntington's disease, robust regional decreases in grey matter density (p<0.001, corrected for multiple comparisons)—that is, atrophy—were found bilaterally in striatal areas as well as in the hypothalamus and the opercular cortex, and unilaterally in the right paracentral lobule. The topography of striatal changes corresponded to the dorso-ventral gradient of neuronal loss described in neuropathological studies. Stratification according to clinical severity showed a more widespread involvement extending into the ventral aspects of the striatum in the group of more severely affected patients.

Conclusions: The topography of cerebral volume changes associated with Huntington's disease can be mapped using VBM. It can be shown that cerebral grey matter changes co-vary with clinical severity and CAG repeat length.

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashburner J., Friston K. J. Voxel-based morphometry--the methods. Neuroimage. 2000 Jun;11(6 Pt 1):805–821. doi: 10.1006/nimg.2000.0582. [DOI] [PubMed] [Google Scholar]
  2. Ashburner J., Friston K. J. Why voxel-based morphometry should be used. Neuroimage. 2001 Dec;14(6):1238–1243. doi: 10.1006/nimg.2001.0961. [DOI] [PubMed] [Google Scholar]
  3. Aylward E. H., Codori A. M., Rosenblatt A., Sherr M., Brandt J., Stine O. C., Barta P. E., Pearlson G. D., Ross C. A. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Mov Disord. 2000 May;15(3):552–560. doi: 10.1002/1531-8257(200005)15:3<552::AID-MDS1020>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  4. Aylward E. H., Li Q., Stine O. C., Ranen N., Sherr M., Barta P. E., Bylsma F. W., Pearlson G. D., Ross C. A. Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology. 1997 Feb;48(2):394–399. doi: 10.1212/wnl.48.2.394. [DOI] [PubMed] [Google Scholar]
  5. Good C. D., Ashburner J., Frackowiak R. S. Computational neuroanatomy: new perspectives for neuroradiology. Rev Neurol (Paris) 2001 Sep;157(8-9):797–806. [PubMed] [Google Scholar]
  6. Good C. D., Johnsrude I. S., Ashburner J., Henson R. N., Friston K. J., Frackowiak R. S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage. 2001 Jul;14(1 Pt 1):21–36. doi: 10.1006/nimg.2001.0786. [DOI] [PubMed] [Google Scholar]
  7. Good Catriona D., Scahill Rachael I., Fox Nick C., Ashburner John, Friston Karl J., Chan Dennis, Crum William R., Rossor Martin N., Frackowiak Richard S. J. Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage. 2002 Sep;17(1):29–46. doi: 10.1006/nimg.2002.1202. [DOI] [PubMed] [Google Scholar]
  8. Harris G. J., Codori A. M., Lewis R. F., Schmidt E., Bedi A., Brandt J. Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease. Brain. 1999 Sep;122(Pt 9):1667–1678. doi: 10.1093/brain/122.9.1667. [DOI] [PubMed] [Google Scholar]
  9. Harris G. J., Pearlson G. D., Peyser C. E., Aylward E. H., Roberts J., Barta P. E., Chase G. A., Folstein S. E. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease. Ann Neurol. 1992 Jan;31(1):69–75. doi: 10.1002/ana.410310113. [DOI] [PubMed] [Google Scholar]
  10. Heinsen H., Rüb U., Bauer M., Ulmar G., Bethke B., Schüler M., Böcker F., Eisenmenger W., Götz M., Korr H. Nerve cell loss in the thalamic mediodorsal nucleus in Huntington's disease. Acta Neuropathol. 1999 Jun;97(6):613–622. doi: 10.1007/s004010051037. [DOI] [PubMed] [Google Scholar]
  11. Kassubek Jan, Juengling Freimut D., Hellwig Bernhard, Spreer Joachim, Lücking Carl H. Thalamic gray matter changes in unilateral Parkinsonian resting tremor: a voxel-based morphometric analysis of 3-dimensional magnetic resonance imaging. Neurosci Lett. 2002 Apr 19;323(1):29–32. doi: 10.1016/s0304-3940(02)00111-8. [DOI] [PubMed] [Google Scholar]
  12. Kremer H. P., Roos R. A., Dingjan G. M., Bots G. T., Bruyn G. W., Hofman M. A. The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington's disease. Neurosci Lett. 1991 Oct 28;132(1):101–104. doi: 10.1016/0304-3940(91)90443-w. [DOI] [PubMed] [Google Scholar]
  13. Kremer H. P., Roos R. A., Dingjan G., Marani E., Bots G. T. Atrophy of the hypothalamic lateral tuberal nucleus in Huntington's disease. J Neuropathol Exp Neurol. 1990 Jul;49(4):371–382. doi: 10.1097/00005072-199007000-00002. [DOI] [PubMed] [Google Scholar]
  14. Lange H., Thörner G., Hopf A., Schröder K. F. Morphometric studies of the neuropathological changes in choreatic diseases. J Neurol Sci. 1976 Aug;28(4):401–425. doi: 10.1016/0022-510x(76)90114-3. [DOI] [PubMed] [Google Scholar]
  15. Mummery C. J., Patterson K., Price C. J., Ashburner J., Frackowiak R. S., Hodges J. R. A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory. Ann Neurol. 2000 Jan;47(1):36–45. [PubMed] [Google Scholar]
  16. Penney J. B., Jr, Vonsattel J. P., MacDonald M. E., Gusella J. F., Myers R. H. CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol. 1997 May;41(5):689–692. doi: 10.1002/ana.410410521. [DOI] [PubMed] [Google Scholar]
  17. Rombouts S. A., Barkhof F., Witter M. P., Scheltens P. Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett. 2000 May 19;285(3):231–233. doi: 10.1016/s0304-3940(00)01067-3. [DOI] [PubMed] [Google Scholar]
  18. Rosas H. D., Goodman J., Chen Y. I., Jenkins B. G., Kennedy D. N., Makris N., Patti M., Seidman L. J., Beal M. F., Koroshetz W. J. Striatal volume loss in HD as measured by MRI and the influence of CAG repeat. Neurology. 2001 Sep 25;57(6):1025–1028. doi: 10.1212/wnl.57.6.1025. [DOI] [PubMed] [Google Scholar]
  19. Rosas H. D., Liu A. K., Hersch S., Glessner M., Ferrante R. J., Salat D. H., van der Kouwe A., Jenkins B. G., Dale A. M., Fischl B. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology. 2002 Mar 12;58(5):695–701. doi: 10.1212/wnl.58.5.695. [DOI] [PubMed] [Google Scholar]
  20. Shoulson I., Fahn S. Huntington disease: clinical care and evaluation. Neurology. 1979 Jan;29(1):1–3. doi: 10.1212/wnl.29.1.1. [DOI] [PubMed] [Google Scholar]
  21. Shoulson I., Odoroff C., Oakes D., Behr J., Goldblatt D., Caine E., Kennedy J., Miller C., Bamford K., Rubin A. A controlled clinical trial of baclofen as protective therapy in early Huntington's disease. Ann Neurol. 1989 Mar;25(3):252–259. doi: 10.1002/ana.410250308. [DOI] [PubMed] [Google Scholar]
  22. Sotrel A., Paskevich P. A., Kiely D. K., Bird E. D., Williams R. S., Myers R. H. Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology. 1991 Jul;41(7):1117–1123. doi: 10.1212/wnl.41.7.1117. [DOI] [PubMed] [Google Scholar]
  23. Sánchez-Pernaute R., García-Segura J. M., del Barrio Alba A., Viaño J., de Yébenes J. G. Clinical correlation of striatal 1H MRS changes in Huntington's disease. Neurology. 1999 Sep 11;53(4):806–812. doi: 10.1212/wnl.53.4.806. [DOI] [PubMed] [Google Scholar]
  24. Thieben M. J., Duggins A. J., Good C. D., Gomes L., Mahant N., Richards F., McCusker E., Frackowiak R. S. J. The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain. 2002 Aug;125(Pt 8):1815–1828. doi: 10.1093/brain/awf179. [DOI] [PubMed] [Google Scholar]
  25. Vonsattel J. P., DiFiglia M. Huntington disease. J Neuropathol Exp Neurol. 1998 May;57(5):369–384. doi: 10.1097/00005072-199805000-00001. [DOI] [PubMed] [Google Scholar]
  26. Vonsattel J. P., Myers R. H., Stevens T. J., Ferrante R. J., Bird E. D., Richardson E. P., Jr Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol. 1985 Nov;44(6):559–577. doi: 10.1097/00005072-198511000-00003. [DOI] [PubMed] [Google Scholar]
  27. de la Monte S. M., Vonsattel J. P., Richardson E. P., Jr Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol. 1988 Sep;47(5):516–525. doi: 10.1097/00005072-198809000-00003. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES